📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
In 2024, Mediclinic Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Mediclinic Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Mediclinic Group’s data sources below and access millions more through our Disclosure Search.
In 2024, the total operational greenhouse gas (GHG) emissions ofMediclinic Group amounted to216,568metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Mediclinic Groupincreased by 18.41%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
In 2024, the total Scope 1 emissions of Mediclinic Group were 78,028 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Since 2019, Mediclinic Group's Scope 1 emissions have increased by 166.87%, reflecting a rising long-term trend in Scope 1 emissions over time.ac
Compared to the previous year(2023), Mediclinic Group's Scope 1 emissions increased by 83.38%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
In 2024, Mediclinic Group reported Scope 2 greenhouse gas (GHG) emissions of 138,540 tCOâ‚‚e using the market-based method.a
Since 2019, Mediclinic Group's Scope 2 greenhouse gas (GHG) emissions (Market-Based)have decreased by 34.25%, reflecting a declining long-term trend in Scope 2 emissions over time.ac
Compared to the previous year(2023), Mediclinic Group's Scope 2 emissions(Market-Based) have remained relatively stable, indicating that Mediclinic Group's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2024, Mediclinic Group reported its Scope 2 emissions using the market-based method.a
In 2024, Mediclinic Group reported 97,892 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of Mediclinic Group includes a breakdown across 0of the 15 Scope 3 categories defined by the GHG Protocol,matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2024, Mediclinic Group reported total Scope 3 emissions of 97,892 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Since 2019, Mediclinic Group's Scope 3 emissionshave increased by 65.98%, reflecting a rising long-term trend in Scope 3 emissions over time.ac
Compared to the previous year (2023), Mediclinic Group's Scope 3 emissions decreased by 16.42%, highlighting the company's efforts to lower indirect emissions from its value chain.a
In 2024, Mediclinic Group reported Scope 1 greenhouse gas (GHG) emissions of 78,028 tCOâ‚‚e and total revenues of USD 4,592 millions. This translates into an emissions intensity of 16.99 tCOâ‚‚e per millions USD.a
In 2024, Mediclinic Group reported a Scope 1 emissions intensity of 16.99 tCOâ‚‚e per millions USD. Compared to the peer group median of 8.92, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2024, Mediclinic Group ranked 21 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a
This places Mediclinic Group among the least efficient performers, with one of the highest emissions intensities in its sector.a
In 2024, Mediclinic Group reported a total carbon footprint of 314,460 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 4.81% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to Mediclinic Group's total carbon footprint was Scope 2 emissions, accounting for 44.06% of the company's total carbon footprint, followed by Scope 3 emissions at 31.13%.a